Supraventricular tachycardia causing heart failure

Current Opinion in Cardiology

Volumn 26, Issue 3, 2011, Pages 261-269

  Houmsse, Mahmoud ^a,b   Tyler, Jaret ^a   Kalbfleisch, Steven ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

heart failure; supraventricular tachycardia; tachycardia induced cardiomyopathy

Indexed keywords

ANTIARRHYTHMIC AGENT;

ABLATION THERAPY; CLINICAL EVALUATION; ELECTROCARDIOGRAPHY; EXTRACELLULAR MATRIX; FOLLOW UP; HEART FAILURE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA INDUCED CARDIOMYOPATHY;

AGE FACTORS; CARDIOMYOPATHIES; CATHETER ABLATION; FEMALE; HEART FAILURE; HUMANS; MALE; RISK FACTORS; TACHYCARDIA, SUPRAVENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79955058637     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328345b010     Document Type: Review

References (48)

1. Gaasch WH, Zile MR. Evaluation of myocardial function in cardiomyopathic states. Prog Cardiovasc Dis 1984; 27:115-132. (Pubitemid 14042072)
2. Damiano RJ, Tripp HF, Asano T, et al. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia. J Thorac Cardiovasc Surg 1987; 94:135-143. (Pubitemid 17093919)
3. Gillette PC, Smith RT, Garson A Jr, et al. Chronic supraventricular tachycardia: a curable cause of congestive cardiomyopathy. JAMA 1985; 253:391-392. (Pubitemid 15193611)
4. Packer DL, BardyGH, Worley SJ, et al. Tachycardia induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 1986; 57:563-570. (Pubitemid 16015939)
5. Zellner JL, Spinale FG, Eble DM, et al. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res 1991; 69:590-600.
6. Gossage AM, Hicks B. On auricular fibrillation. Q J Med 1913; 6:435-440.
7. Whipple GH, Sheffield LT, Woodman EG, et al. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 1962; 20:39-40.
8. Khasnis A, Jongnarangsin K, Abela G, et al. Tachycardia-induced cardiomyopathy: a review of literature. PACE 2005; 28:710-721. (Pubitemid 41001445)
9. Medi C, Kalman JM, Haqqani H, et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol 2009; 53:1791-1797.
10. Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. JACC 1997; 29:709-715. (Pubitemid 27128241)
11. Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation 2004; 110:247-252. (Pubitemid 38960795)
12. Pizzale S, Lemery R, Green MS, et al. Frequency and predictors of tachycardia- induced cardiomyopathy in patients with persistent atrial flutter. Can J Cardiol 2009; 25:469-472.
13. Meiltz A, Weber R, Halimi F, Zimmermann M, et al., for the RETAC (Ré seau Européen pour le Traitement des Arythmies Cardiaques). Permanent form of junctional reciprocating tachycardia in adults: peculiar features and results of radiofrequency catheter ablation. Europace 2006; 8:21-28.
14. Harrigan JT, Kangos JJ, Sikka A, et al. Successful treatment of fetal congestive heart failure secondary to tachycardia. N Engl J Med 1981; 304:1527-1529. (Pubitemid 11065938)
15. Ott P, Kelly PA, Mann DE, et al. Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: treatment with radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1995; 6:391-395.
16. Morgan DE, Tomlinson CW, Qayumi AK, et al. Evaluation of ventricular contractility indexes in the dog with blood ventricular dysfunction induced by rapid atrial pacing. JACC 1989; 14:496.
17. O'Brien PJ, Ianuzzo CD, Moe GW, et al. Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies. Can J Physiol Pharmacol 1990; 68:34.
18. Ohno M, Cheng CP, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994; 89:2241.
19. Wilson JR, Douglas P, Hickey WF, et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog. Circulation 1987; 75:857.
20. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circulation 1991; 83:635-644.
21. Fishberger SB, Golan S, Saul JP, et al. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol 1996; 19:42.
22. Gopinathannair R, Sullivan RM, Olshansky B. Tachycardia-mediated cardiomyopathy: recognition and management. Curr Heart Failure Rep 2009; 6:257-264.
23. Spinale FG, Hendrick DA, Crawford FA, et al. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol 1990; 259:H218-H229. (Pubitemid 20247737)
24. Wilson JR, Douglas P, Hickey WF, et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 1987; 75:857-867. (Pubitemid 17052671)
25. Zellner JL, Spinale FG, Eble DM, et al. Alterations in myocyte shape and basement membrane attachment with tachycardia induced heart failure. Circ Res 1991; 69:590-600.
26. Spinale FG, Zellner JL, Johnson WS, et al. Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. J Mol Cell Cardiol 1996; 28:1591-1608. (Pubitemid 26302217)
27. Spinale FG, Grine RC, Tempel GE, et al. Alteration in the myocardial capillary vasculature accompanies tachycardia-induced cardiomyopathy. Basic Res Cardiol 1992; 187:65-79.
28. Spinale FG, Hendrick DA, Crawford FA, et al. Chronic supraventricular tachycardia causes biventricular failure and subendocardial injury. Am J Physiol 1990; 259:H218-H229. (Pubitemid 20247737)
29. Kono T, Sabbah HN, Rosman H, et al. Left ventricular shape is the primary determinant of functional regurgitation in heart failure. J Am Coll Cardiol 1992; 20:1594-1598. (Pubitemid 23007515)
30. Sabbah HN, Rosman H, Kono T, et al. On the mechanism of functional mitral regurgitation. Am J Cardiol 1993; 72:1074-1076. (Pubitemid 23319932)
31. Boltwood CM, Tei C, Wong M, et al. Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation. Circulation 1983; 68:498-508. (Pubitemid 13050587)
32. He S, Fontaine AA, Schwammenthal E, et al. Integrated mechanism for functional mitral regurgitation. Circulation 1997; 96:1826-1834.
33. Otsuji Y, Handschumacher MD, Schwammenthal E, et al. Insight from threedimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997; 96:1999-2008. (Pubitemid 27400764)
34. Timek TA, Dagum P, Lai DT, et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy. Circulation 2001; 104 (Suppl I):I-47-I- 53.
35. Stephens EH, Timek TA, Daughters GT, et al. Significant changes in mitral valve leaflet matrix composition and turnover with tachycardia-induced cardiomyopathy. Circulation 2009; 120:S112-S119.
36. Porter MJ, Morton JB, Denman R, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm 2004; 1:393-396. (Pubitemid 39462609)
37. Iturralde P, Nava S, Sá lica G, et al. Electrocardiographic characteristics of patients with Ebstein's anomaly before and after ablation of an accessory atrioventricular pathway. J Cardiovasc Electrophysiol 2006; 17:1332-1336. (Pubitemid 44808554)
38. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983-988.
39. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271:840-844.
40. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995; 98:476-484.
41. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110:364-367. (Pubitemid 38993843)
42. Armstrong PW, Stopps TP, Ford SE, De Bold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 1986; 74:1075-1084. (Pubitemid 17174956)
43. Saoudi N, Cosio F,Waldo A, et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic basis: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 2001; 12:852-866. (Pubitemid 32607277)
44. Erbel R, Schweizer P, Krebs W, et al. Sensitivity and specificity of twodimensional echocardiography in detection of impaired left ventricular function. Eur Heart J 1984; 5:477.
45. Felker GM, Thomson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342:1077.
46. Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol 1996; 78:1433-1436. (Pubitemid 126657243)
47. Khan MN, Jais P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008; 359:1778-1785.
48. Ilkhanoff L, Gerstenfeld EP, Zado ES, Marchlinski FE. Changes in ventricular dimensions and function during recovery of atrial tachycardia-induced cardiomyopathy treated with catheter ablation. J Cardiovasc Electrophysiol 2007; 18:1104-1106. (Pubitemid 47416559)